Original Research
Accepted on 28 Aug 2025
Rituximab retreatment guided by CD27+ B-cell count versus clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 28 Aug 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 28 Aug 2025
in Plant Breeding
Original Research
Accepted on 28 Aug 2025
in Sustainable and Intelligent Phytoprotection
Original Research
Accepted on 28 Aug 2025
in Neurological Biomarkers
Original Research
Accepted on 28 Aug 2025
in Neurotrauma
Original Research
Accepted on 28 Aug 2025
in Plant Nutrition
Original Research
Accepted on 28 Aug 2025
in Sustainable and Intelligent Phytoprotection
Original Research
Accepted on 28 Aug 2025
in Neurocritical and Neurohospitalist Care
Original Research
Accepted on 28 Aug 2025
in Agroecological Cropping Systems
Brief Research Report
Accepted on 28 Aug 2025
in Agroecological Cropping Systems
Correction
Accepted on 28 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Aug 2025
in Freshwater Science
Original Research
Published on 28 Aug 2025
in Neurocritical and Neurohospitalist Care
Original Research
Published on 28 Aug 2025
in Headache
Original Research
Published on 28 Aug 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 28 Aug 2025
in Nuclear Medicine